Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Blog
>
2021
Blog, 2021
DISCOVERY BIOLOGY
ChemDiv offers a suite of discovery biology services.
VISIT OUR VIRTUAL BOOTH AT THE EUROPEAN CHEMICAL BIOLOGY SYMPOSIUM
The virtual European Chemical Biology Symposium ECBS2021 is co-organised by the EuChemS Division “Chemistry in Life Sciences” (LS-EuChemS) and EU-OPENSCREEN ERIC and brings together scient...
CHEMDIV IS YOUR PARTNER MEDICINAL CHEMISTRY
We support you in every step of the process to improve specific parameters of molecules and progress series from a hit to a lead and to a successful clinical candidate.
DNA ENCODED LIBRARIES-CDI-CAPABILITIES
ChemDiv proposes design and synthesis of heterocyclic scaffolds for DNA Encoded Libraries-CDI-Capabilities.
MAY IS HEPATITIS AWARENESS MONTH
Worldwide, 500 million people are estimated to be infected with hepatitis B or C.
YOUR OPINION MATTERS
Note from ChemDiv Customer Care.
CUSTOM CHEMISTRY
https.
ADMET / DMPK
ADME (absorption, distribution, metabolism and excretion) properties are crucial for understanding the safety and efficacy of a drug candidate, increasing the likelihood of a successful p...
APRIL IS SARCOIDOSIS AWARENESS MONTH
Sarcoidosis is a rare, auto-immune disease that can cause inflammation and scarring of body tissue.
FLUORINE AND BROMINE FRAGMENTS
Fluorine Fragments (1,480 compounds)Bromine Fragments (629 compounds)ChemDiv’s Crystallographic and 19F NMR fragment libraries contain Fluorine Fragments (1,480 compounds) an...
AKT LIBRARY
ChemDiv presents the new Akt Library of over 15,000 compounds.
PROTEOLYSIS TARGETING CHIMERAS (PROTAC)
Extensive experience in the synthesis of active PROTAC molecules for wide range of biological targets, from kinases to nuclear hormone receptors.
1
2
3
4
5
6
7
